NCT01119560

Genetic Susceptibility Biomarkers in Children With Neuroblastoma (Also Known as Neuroblastoma Epidemiology in North America [NENA])

Study Contact:

Study Phase:

Recruitment Status:

COMPLETED

NCT ID:

NCT01119560

Principal Investigator:

Study Type:

OBSERVATIONAL

Official Title:

Genetic Susceptibility Factors in the Etiology of Neuroblastoma Also Known as Neuroblastoma Epidemiology in North America (NENA)

Summary

This research trial studies the genes biomarkers in children with neuroblastoma. Studying the genes in a child's cancer cells may help doctors improve ways to diagnose and treat children with neuroblastoma.

Eligibility

Inclusion Criteria:

* Primary diagnosis of neuroblastoma made at a North American COG institution
* Diagnosed between 12/24/2007- 7/31/2013
* Diagnosed at < 6 years of age
* Biological mother is alive and willing to participate
* Questionnaire respondents must understand English or Spanish
* Are only those participating in CCRN who have agreed to be contacted for future studies

Disease(s) and\or Condition(s)

Neuroblastoma

Primary Purpose

Intervention/Treatment

- Type: OTHER
- Name: Cytology Specimen Collection Procedure
- Description: Correlative studies
- Arm Group Labels: Ancillary-Correlative (Questionnaire, saliva & tissue sample)
- Type: OTHER
- Name: Laboratory Biomarker Analysis
- Description: Correlative studies
- Arm Group Labels: Ancillary-Correlative (Questionnaire, saliva & tissue sample)
- Type: OTHER
- Name: Questionnaire Administration
- Description: Ancillary studies
- Arm Group Labels: Ancillary-Correlative (Questionnaire, saliva & tissue sample)

Sponsor

Children's Oncology Group